Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

CA Battles Whooping Cough Epidemic

December 12, 2014 11:07 am | News | Comments

California officials are battling the worst whooping cough epidemic to hit the state in seven decades as a recent rebound in cases raises questions about the effectiveness of the pertussis vaccine. Read more...                    

TOPICS:

Taming Inflammatory Response in Kidney Dialysis

December 12, 2014 11:02 am | News | Comments

Over the past several years, lead author John Lambris, PhD, the Dr. Ralph and Sallie Weaver Professor of Research Medicine, Perelman School of Medicine at the University of  Pennsylvania, and his colleagues have developed small molecule versions of the drug compstatin, which inhibits a component of the complement immune response called C3. Read more...

TOPICS:

Hep C Ruled Out as Mental Impairment Cause in HIV

December 12, 2014 10:52 am | by Michael C. Purdy, Washington University | News | Comments

Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer. As they age, however, many experience impaired thinking, memory loss, mood swings and other evidence of impaired mental function. Read more... 

TOPICS:
Advertisement

Understanding Intestinal Microbiota to Regain Balance in the Gut

December 12, 2014 10:42 am | by Natalie Duggan, Emory | News | Comments

When you take antibiotics, some of the beneficial germs can be wiped out, leaving you more vulnerable to diarrheal infections—infections, in some cases, that are antibiotic resistant and life-threatening. Read more...                                    

TOPICS:

TWi Biotechnology Receives FDA Protocols for Gout Drug

December 12, 2014 10:30 am | News | Comments

TWi Biotechnology Inc. has received US FDA and Taiwan FDA approval of a protocol for a Phase 2 clinical trial of gout drug. Read more...                     

TOPICS:

Merck Helps Africa Fight Parasitic Worm Disease

December 12, 2014 10:22 am | News | Comments

Merck announced that Ethiopia will receive around 13 million praziquantel tablets in 2015. Read more...                          

TOPICS:

Abbott Acquires Veropharm for $305M

December 12, 2014 9:56 am | News | Comments

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Read more...                        

TOPICS:

Team Discovers Reasons for Malaria's Drug Resistance

December 12, 2014 9:38 am | by Nanyang Technological University | News | Comments

Scientists have discovered exactly how the malaria parasite is developing resistance towards the most important front-line drugs used to treat the disease. Read more...                

TOPICS:
Advertisement

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Avian Flu Spreading in Southwest British Columbia

December 12, 2014 9:27 am | News | Comments

Avian influenza poses little danger to people as long as poultry meat is handled and cooked properly. Read more...                         

TOPICS:

Mali: Last Known Ebola Case Cured, Released

December 12, 2014 9:22 am | by Sarah Dilorenzo - Associated Press | News | Comments

The last Ebola patient being treated in Mali has survived the disease and been released. Read more...                           

TOPICS:

Minnesota Board Won't Set Rules on Execution Drugs

December 11, 2014 2:09 pm | by Brian Bakst - Associated Press | News | Comments

Minnesota pharmacy regulators declined Wednesday to set a pioneering policy sought by death-penalty opponents that would explicitly bar the manufacture of lethal drugs for use in executions elsewhere. Read more...        

TOPICS:

Drug Class Shows Promising Results for Breast Cancer Therapy

December 11, 2014 11:53 am | News | Comments

A new class of drugs could help overcome resistance to standard treatments. Read more...                             

TOPICS:

Epidemics Are Optional

December 11, 2014 11:37 am | by Kalpana Jain, Harvard Divinity School Communications | News | Comments

The large number of deaths from the Ebola virus is primarily due to the lack of sufficient medical care where it’s needed most. Read more...                    

TOPICS:

Merck Advancing Breast Cancer Drug to Mid-Stage

December 11, 2014 11:33 am | by Linda A. Johnson - AP Business Writer | News | Comments

Merck said it will start mid-stage patient tests of Keytruda in the first half of 2015. Read more...                           

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading